Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alnylam, Anagram, Angitia, Ascendis, BMS, Bridgebio, Cereno, Cour, CSL, Enliven, Estrella, Janssen, Kezar, Madrigal, Neurobo, Ocuphire, Pop, Poseida, Rivus, Windtree.